Journal of Diagnostics Concepts & Practice ›› 2017, Vol. 16 ›› Issue (05): 498-503.doi: 10.16150/j.1671-2870.2017.05.009
• Original articles • Previous Articles Next Articles
WANG Shu, ZHANG Yunxiang, SUI Jingni, LU Jing, FAN Huiyong, WANG Chao, CHEN Bing
Received:
2017-07-30
Online:
2017-10-25
Published:
2017-10-25
CLC Number:
WANG Shu, ZHANG Yunxiang, SUI Jingni, LU Jing, FAN Huiyong, WANG Chao, CHEN Bing.. Analysis of additional mutation pattern accompanied with CEBPA mutations in patients with the cytogenetically normal acute myeloid leukemia[J]. Journal of Diagnostics Concepts & Practice, 2017, 16(05): 498-503.
[1] Szczepański T, Harrison CJ, van Dongen JJ. Genetic aberrations in paediatric acute leukaemias and implications for management of patients[J]. Lancet Oncol,2010, 11(9):880-889. [2] Ley TJ, Miller C, Ding L, et al.Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia[J]. N Engl J Med,2013,368(22):2059-2074. [3] Papaemmanuil E, Gerstung M, Bullinger L, et al.Genomic Classification and Prognosis in Acute Myeloid Leukemia[J]. N Engl J Med,2016,374(23):2209-2221. [4] NCCN Cliinical Practice Guidelines in Oncology-----Acute Myeloid Leukemia[R/OL]. https://www.nccn.org/National Comprehensive Cancer Network,NCCN Cliinical Practice Guidelines in Oncology-----Acute Myeloid Leukemia[R/OL]. https://www.nccn.org/National Comprehensive Cancer Network,Inc,2017,2:24. [5] Döhner H, Estey E, Grimwade D, et al. Diagnosis and management of AML in adults:2017 ELN recommendations from an international expert panel[J]. Blood,2017 Jan 26,129(4):424-447. [6] Ley TJ, Ding L, Walter MJ, et al.DNMT3A mutations in acute myeloid leukemia[J]. N Engl J Med,2010,363(25):2424-2433. [7] Yan XJ, Xu J, Gu ZH, et al.Exome sequencing identifies somatic mutations of DNA methyltransferase gene DNMT3A in acute monocytic leukemia[J]. Nat Genet,2011, 43(4):309-315. [8] Döhner H, Weisdorf DJ, Bloomfield CD.Acute myeloid Leukemia[J]. N Engl J Med,2015,373(12):1136-1152. [9] Fasan A, Haferlach C, Alpermann T, et al.The role of different genetic subtypes of CEBPA mutated AML[J]. Leukemia,2014,28(4):794-803. [10] Pabst T, Mueller BU, Zhang P, et al.Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-alpha (C/EBPalpha), in acute myeloid leukemia[J]. Nat Genet,2001,27(3):263-270. [11] Timchenko NA, Wilde M, Nakanishi M, et al.CCAAT/enhancer-binding protein alpha (C/EBP alpha) inhibits cell proliferation through the p21 (WAF-1/CIP-1/SDI-1) protein[J]. Genes Dev,1996,10(7):804-815. [12] Pabst T, Eyholzer M, Fos J, et al.Heterogeneity within AML with CEBPA mutations; only CEBPA double mutations, but not single CEBPA mutations are associated with favourable prognosis[J]. Br J Cancer,2009,100(8):1343-1346. [13] Arber DA, Orazi A, Hasserjian R, et al.The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia[J]. Blood,2016, 127(20):2391-2405. [14] NCCN Cliinical Practice Guidelines in Oncology-----Acute Myeloid Leukemia[R/OL]. https://www.nccn.org/National Comprehensive Cancer Network,NCCN Cliinical Practice Guidelines in Oncology-----Acute Myeloid Leukemia[R/OL]. https://www.nccn.org/National Comprehensive Cancer Network,Inc,2017:25. [15] Döhner H, Estey E, Grimwade D, et al.Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel[J]. Blood, 2017 ,129(4):424-447. [16] Ghanem H, Tank N, Tabbara IA.Prognostic implications of genetic aberrations in acute myelogenous leukemia with normal cytogenetics[J]. Am J Hematol,2012,87(1):69-77. [17] Shin SY, Lee ST, Kim HJ, et al.Mutation profiling of 19 candidate genes in acute myeloid leukemia suggests significance of DNMT3A mutations[J]. Oncotarget,2016,7(34):54825-54837. [18] Wakita S, Yamaguchi H, Ueki T, et al.Complex molecular genetic abnormalities involving three or more genetic mutations are important prognostic factors for acute myeloid leukemia[J]. Leukemia,2016,30(3):545-554. [19] Peterlin P, Renneville A, Ben Abdelali R, et al.Impact of additional genetic alterations on the outcome of patients with NPM1-mutated cytogenetically normal acute myeloid leukemia[J]. Haematologica,2015,100(5):e196-e199. [20] Shen Y, Zhu YM, Fan X, et al.Gene mutation patterns and their prognostic impact in a cohort of 1185 patients with acute myeloid leukemia[J]. Blood,2011,118(20):5593-5603. [21] Pastore F, Kling D, Hoster E, et al.Long-term follow-up of cytogenetically normal CEBPA-mutated AML[J]. J Hematol Oncol,2014,7:55. [22] Daniel A, Arber AO, Robert H, et al.The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia[M]. Lyon: IARC,2016. [23] Wouters BJ, Löwenberg B, Erpelinck-Verschueren CA, et al.Double CEBPA mutations, but not single CEBPA mutations, define a subgroup of acute myeloid leukemia with a distinctive gene expression profile that is uniquely associated with a favorable outcome[J]. Blood,2009,113(13):3088-3091. [24] Borthakur G, Kantarjian H, Patel KP, et al.Impact of numerical variation in FMS-like tyrosine kinase receptor 3 internal tandem duplications on clinical outcome in normal karyotype acute myelogenous leukemia[J]. Cancer,2012,118(23):5819-5822. [25] Renneville A, Boissel N, Nibourel O, et al.Prognostic significance of DNA methyltransferase 3A mutations in cytogenetically normal acute myeloid leukemia: a study by the Acute Leukemia French Association[J]. Leukemia,2012,26(6):1247-1254. [26] Wang JH, Chen WL, Li JM, et al.Prognostic significance of 2-hydroxyglutarate levels in acute myeloid leukemia in China[J]. Proc Natl Acad Sci U S A,2013,110(42):17017-17022. [27] Weissmann S, Alpermann T, Grossmann V, et al.Landscape of TET2 mutations in acute myeloid leukemia[J]. Leukemia,2012,26(5):934-942. |
[1] | GAO Yanting, ZHAO Jinyan, WANG Juan, LI Jia, XU Wen, LI Li, LIN Lihui. Analysis of bone marrow lymphocyte subsets in patients with acute myeloid leukemia and its clinical significance [J]. Journal of Diagnostics Concepts & Practice, 2020, 19(04): 407-413. |
[2] | XU Zhaoping, WANG Haofei. Expression of ZNF692 gene in clear cell renal cell carcinoma and its relationship with prognosis [J]. Journal of Diagnostics Concepts & Practice, 2020, 19(03): 292-296. |
[3] | PENG Zhenping, XIANG Xixi, ZHANG Sujiang, LI Jiaming. Chronic neutrophilic leukemia with leukemia-like reaction as the first-onset manifestation: a report of 2 cases and literature review [J]. Journal of Diagnostics Concepts & Practice, 2020, 19(02): 122-128. |
[4] | WEI Jian, GAO Pingjin, HAN Weiqing. Effect of α7 nicotinic acetylcholine receptor activation on transforming growth factor β1-induced phenotypic transformation of adventitia fibroblasts studied in vitro [J]. Journal of Diagnostics Concepts & Practice, 2019, 18(1): 56-60. |
[5] | CHEN Ying, LI Cui, YING Chunmei. Expression of T cell immunoglobulin and immunoreceptor tyrosine-based inhibitory motif domain on T cells in patients with recurrent spontaneous abortion [J]. Journal of Diagnostics Concepts & Practice, 2017, 16(03): 273-276. |
[6] | ZHU Jianyi, LANG Wenjing, CHEN Fangyuan, XU Zhuoran, SHEN Lijing, ZHONG Jihua. Effect of arsenic trioxide on EVI1 gene in regulating hematopoietic transcription factors in vitro [J]. Journal of Diagnostics Concepts & Practice, 2017, 16(01): 42-47. |
[7] | . [J]. Journal of Diagnostics Concepts & Practice, 2016, 15(03): 283-286. |
[8] | . [J]. Journal of Diagnostics Concepts & Practice, 2014, 13(02): 176-181. |
[9] | . [J]. Journal of Diagnostics Concepts & Practice, 2013, 12(03): 315-319. |
[10] | . [J]. Journal of Diagnostics Concepts & Practice, 2013, 12(02): 185-188. |
[11] | . [J]. Journal of Diagnostics Concepts & Practice, 2013, 12(02): 189-193. |
[12] | . [J]. Journal of Diagnostics Concepts & Practice, 2013, 12(01): 90-94. |
[13] | . [J]. Journal of Diagnostics Concepts & Practice, 2012, 11(05): 498-501. |
[14] | . [J]. Journal of Diagnostics Concepts & Practice, 2012, 11(03): 252-257. |
[15] | . [J]. Journal of Diagnostics Concepts & Practice, 2011, 10(06): 540-544. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||